Polyarteritis nodosa is an unforeseen borderline paradoxical adverse reaction in a female patient with rheumatoid arthritis treated with tofacitinib

The paper describes the occurrence of polyarteritis nodosa in a patient with rheumatoid arthritis during treatment with tofacitinib. It considers the reasons why this condition should be regarded as an unforeseen borderline paradoxical adverse reaction.

Bibliographic Details
Main Authors: Yu. V. Muraviev, S. G. Radenska-Lopovok, V. V. Lebedeva, S. Yu. Alamankina
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2019-09-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/944
_version_ 1826556844602032128
author Yu. V. Muraviev
S. G. Radenska-Lopovok
V. V. Lebedeva
S. Yu. Alamankina
author_facet Yu. V. Muraviev
S. G. Radenska-Lopovok
V. V. Lebedeva
S. Yu. Alamankina
author_sort Yu. V. Muraviev
collection DOAJ
description The paper describes the occurrence of polyarteritis nodosa in a patient with rheumatoid arthritis during treatment with tofacitinib. It considers the reasons why this condition should be regarded as an unforeseen borderline paradoxical adverse reaction.
first_indexed 2024-04-10T02:06:24Z
format Article
id doaj.art-7705bb3319fc4588893b2128aa32c244
institution Directory Open Access Journal
issn 1996-7012
2310-158X
language Russian
last_indexed 2025-03-14T08:19:10Z
publishDate 2019-09-01
publisher IMA-PRESS LLC
record_format Article
series Современная ревматология
spelling doaj.art-7705bb3319fc4588893b2128aa32c2442025-03-02T13:11:02ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2019-09-0113314214310.14412/1996-7012-2019-3-142-1432200Polyarteritis nodosa is an unforeseen borderline paradoxical adverse reaction in a female patient with rheumatoid arthritis treated with tofacitinibYu. V. Muraviev0S. G. Radenska-Lopovok1V. V. Lebedeva2S. Yu. Alamankina3V.A. Nasonova Research Institute of RheumatologyI.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of RussiaV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyThe paper describes the occurrence of polyarteritis nodosa in a patient with rheumatoid arthritis during treatment with tofacitinib. It considers the reasons why this condition should be regarded as an unforeseen borderline paradoxical adverse reaction.https://mrj.ima-press.net/mrj/article/view/944tofacitinibparadoxical adverse reactionvasculitispolyarteritis nodosa
spellingShingle Yu. V. Muraviev
S. G. Radenska-Lopovok
V. V. Lebedeva
S. Yu. Alamankina
Polyarteritis nodosa is an unforeseen borderline paradoxical adverse reaction in a female patient with rheumatoid arthritis treated with tofacitinib
Современная ревматология
tofacitinib
paradoxical adverse reaction
vasculitis
polyarteritis nodosa
title Polyarteritis nodosa is an unforeseen borderline paradoxical adverse reaction in a female patient with rheumatoid arthritis treated with tofacitinib
title_full Polyarteritis nodosa is an unforeseen borderline paradoxical adverse reaction in a female patient with rheumatoid arthritis treated with tofacitinib
title_fullStr Polyarteritis nodosa is an unforeseen borderline paradoxical adverse reaction in a female patient with rheumatoid arthritis treated with tofacitinib
title_full_unstemmed Polyarteritis nodosa is an unforeseen borderline paradoxical adverse reaction in a female patient with rheumatoid arthritis treated with tofacitinib
title_short Polyarteritis nodosa is an unforeseen borderline paradoxical adverse reaction in a female patient with rheumatoid arthritis treated with tofacitinib
title_sort polyarteritis nodosa is an unforeseen borderline paradoxical adverse reaction in a female patient with rheumatoid arthritis treated with tofacitinib
topic tofacitinib
paradoxical adverse reaction
vasculitis
polyarteritis nodosa
url https://mrj.ima-press.net/mrj/article/view/944
work_keys_str_mv AT yuvmuraviev polyarteritisnodosaisanunforeseenborderlineparadoxicaladversereactioninafemalepatientwithrheumatoidarthritistreatedwithtofacitinib
AT sgradenskalopovok polyarteritisnodosaisanunforeseenborderlineparadoxicaladversereactioninafemalepatientwithrheumatoidarthritistreatedwithtofacitinib
AT vvlebedeva polyarteritisnodosaisanunforeseenborderlineparadoxicaladversereactioninafemalepatientwithrheumatoidarthritistreatedwithtofacitinib
AT syualamankina polyarteritisnodosaisanunforeseenborderlineparadoxicaladversereactioninafemalepatientwithrheumatoidarthritistreatedwithtofacitinib